Aggressive Equity is our highest-conviction strategy — built for investors who want to capture exponential returns before the mainstream retail market catches up. We take concentrated positions in pre-IPO technology unicorns, artificial intelligence infrastructure, biotechnology, and emerging market leaders with multi-year growth mandates.
Targets of 83–112% per annum are driven by early and institutional-grade deal access. Volatility is accepted and actively managed. Minimum entry from just $1,000 — no accreditation required.